Insulet (PODD) Cash & Equivalents (2010 - 2026)
Insulet's (PODD) quarterly Cash & Equivalents came in at $480.4 million in Q1 2026, down 62.56% YoY from $1.3 billion in Q1 2025, and down 32.91% on a QoQ basis from $716.1 million in Q4 2025.
Insulet (PODD) Cash & Equivalents (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Cash & Equivalents data on file, last reported at $480.4 million in Q1 2026.
- Quarterly Cash & Equivalents fell 62.56% year-over-year to $480.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $480.4 million (down 62.56% YoY) and the FY2025 annual result came in at $716.1 million, down 24.89% from the prior year.
- Cash & Equivalents declined to $480.4 million in Q1 2026, from $716.1 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $1.3 billion in Q1 2025 to a low of $480.4 million in Q1 2026.
- A 5-year average of $780.7 million and a median of $716.1 million in 2025 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2025 — Cash & Equivalents surged 70.81% — and 2026, when it sank 62.56%.
- Tracing PODD's Cash & Equivalents over 5 years: stood at $674.7 million in 2022, then rose by 4.37% to $704.2 million in 2023, then jumped by 35.39% to $953.4 million in 2024, then slipped by 24.89% to $716.1 million in 2025, then tumbled by 32.91% to $480.4 million in 2026.
- The last three Cash & Equivalents figures came in at $480.4 million (Q1 2026), $716.1 million (Q4 2025), and $757.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Insulet | 10.18 Bn | 9.64 Bn | 562.60 Mn | 534.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 534.90 Mn |
| Mar 31, 2026 | 480.40 Mn |
| Dec 31, 2025 | 716.10 Mn |
| Sep 30, 2025 | 757.40 Mn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 953.40 Mn |
| Sep 30, 2024 | 902.60 Mn |
| Jun 30, 2024 | 821.00 Mn |
| Mar 31, 2024 | 751.20 Mn |
| Dec 31, 2023 | 704.20 Mn |
| Sep 30, 2023 | 685.40 Mn |
| Jun 30, 2023 | 660.10 Mn |
| Mar 31, 2023 | 620.70 Mn |
| Dec 31, 2022 | 674.70 Mn |
| Sep 30, 2022 | 722.00 Mn |
| Jun 30, 2022 | 708.60 Mn |
| Mar 31, 2022 | 709.60 Mn |
| Dec 31, 2021 | 791.60 Mn |
| Sep 30, 2021 | 856.60 Mn |